Daily non-political popular news in brief.
University of Pittsburgh scientists find new contributor to aggressive cancers
06-06-2007 · EurekAlert!Mutations in the cell adhesion molecule known as integrin alpha 7 (integrin б7) lead to unchecked tumor cell proliferation and a significantly higher incidence in cancer spread, or metastasis, in several cancer cell lines, report researchers at the University of Pittsburgh School of Medicine in a study being published today in the Journal of the National Cancer Institute. These findings suggest that integrin б7 represents an important new target for cancer therapy and prevention.
Read more »
Keywords: university, pittsburgh, scientists, contributor, aggressive, cancers, scientist, cancer
« Previous | Next »
Similar news on "University of Pittsburgh scientists find new contributor to aggressive cancers":
- Reversing cancer cells to normal cells
04-29-2007 · EurekAlert!
A Northwestern University scientist describes new research that used an innovative experimental approach to provide unique insights into how scientists can change human metastatic melanoma cells back to normal-like skin cells -- by exposing the tumor cells to the embryonic microenvironment of human embryonic stem cells, the zebra fish and the chick embryo.
Similar news · Read more »
- Einstein scientists treat cancer as an infectious disease -- with promising results
10-30-2007 · EurekAlert!
Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them. The findings, published in the Oct. 31 issue of PloS One, also raise the possibility of preventing cancer by destroying virus-infected cells before they turn cancerous.
Similar news · Read more »
- Src inhibitors may prove beneficial in breast cancer therapy
07-12-2007 · EurekAlert!
Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alpha-negative cancers are more aggressive and have a worse prognosis than do ER-alpha-positive breast cancers, and have been thought to be estrogen independent. In a new JCI study, University of Miami researchers shed further light on the mechanisms regulating ER-alpha expression levels during breast cancer.
Similar news · Read more »
- Probe to detect spread of breast cancer co-developed by UH scientist
03-06-2007 · EurekAlert!
High-temperature superconductors hold the key to a handheld tool for surgeons that promises to be more accurate, cost-effective and safer than existing methods for staging and treating various cancers, including breast cancer. Researchers at University of Houston and University College of London have developed a novel detection procedure, combining nanotechnology and advanced magnetic sensing based on high-temperature superconductors, enabling surgeons to more effectively locate the sentinel lymph node.
Similar news · Read more »
- Extracting eggs from pre-pubertal cancer patients brings hope for future fertility
07-01-2007 · EurekAlert!
Scientists in Israel have been able to obtain and freeze eggs from the ovarian tissue of girls as young as 5 years old, the 23rd Annual Conference of the European Society of Human Reproduction and Embryology will hear on Tuesday, July 3. Dr. Ariel Revel, from the Department of Obstetrics and Gynaecology, Hadassah University Hospital, Jerusalem, Israel said that the growing number of survivors of childhood cancers meant that such techniques would become increasingly important in preserving fertility in young patients.
Similar news · Read more »
- Scientists identify pancreatic cancer stem cells
02-01-2007 · EurekAlert!
Researchers at the University of Michigan Medical Center have, for the first time, identified human pancreatic cancer stem cells. Their work indicates that these cells are likely responsible for the aggressive tumor growth, progression, and metastasis that define this deadly cancer.
Similar news · Read more »
- First familial pancreatic cancer gene identified
12-11-2006 · EurekAlert!
At least 10 percent of pancreatic cancers are thought to be familial, i.e., caused by inherited genetic mutations. The responsible genes have so far remained elusive, but one of the research teams that had been on a pancreatic cancer gene hunt for years now reports success: Teri Brentnall (University of Washington), David Whitcomb (University of Pittsburgh), and colleagues publish the identification of the palladin gene as the one mutated in a large family they had been studying for a while.
Similar news · Read more »
- Natural protein stops deadly human brain cancer in mice
12-07-2006 · EurekAlert!
Scientists from Johns Hopkins and from the University of Milan have effectively proven that they can inhibit lethal human brain cancers in mice using a protein that selectively induces positive changes in the activity of cells that behave like cancer stem cells. The report is published this week in Nature.
Similar news · Read more »
- Biomarkers predict risk for invasive breast cancer years before the tumor develops
11-12-2007 · EurekAlert!
A team of scientists from the University of California San Francisco has identified distinct molecular markers that predict whether or not a woman is likely to develop subsequent invasive cancer after initial diagnosis with a noninvasive form of early breast cancer. The research, published by Cell Press in the November issue of Cancer Cell, provides critical information that can be used to determine whether a woman should receive more or less aggressive therapy.
Similar news · Read more »
- Discovery in plants suggests entirely new approach to treating human cancers
04-04-2007 · EurekAlert!
For the first time, scientists from the University of Washington School of Medicine, Indiana University Bloomington and the University of Cambridge have determined how a plant hormone -- auxin -- interacts with its hormone receptor, called TIR1. Their report, on the cover of this week's issue of Nature, also may have important implications for the treatment of human disease, because TIR1 is similar to human enzymes that are known to be involved in cancer.
Similar news · Read more »
